Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/2012
12/12/2012CN102205114B Application of erythropoietin source peptide to preparation of medicament for treating autoimmune disease of nervous system
12/12/2012CN102166214B Medical application of aminothiazole type MyD88 specific inhibitor
12/12/2012CN102114011B Ibuprofen sustained-release preparation and preparation method thereof
12/12/2012CN102100818B Quality control method for lophanthus antifebrile tablets
12/12/2012CN102038725B Composition for prevention of influenza viral infection comprising sumac extract, air filter comprising the same and air cleaning device comprising the filter
12/12/2012CN102000052B Application of taxol and taxol derivatives to pharmacy
12/12/2012CN101928234B 6/7-(hetero)aryl-N-hydroxyl hexanamide/heptamide compounds and method for preparing same
12/12/2012CN101920042B Liquid bandage and preparation method
12/12/2012CN101919913B Composition with effect of treating rheumatoid arthritis
12/12/2012CN101772507B Proteasome inhibitors
12/12/2012CN101649249B Method for preparing ostrich oil
12/12/2012CN101610775B Analgesic agent comprising cyclic phosphatidic acid derivative
12/12/2012CN101563317B O-substituted-dibenzyl urea-derivatives as trpv1 receptor antagonists
12/12/2012CN101537080B Pine needle health-care medicinal liquor with efficacy of dispersing pathogenic wind and removing dampness and preparation method thereof
12/12/2012CN101340894B Bursting pellets
12/12/2012CN101312746B Preparation containing iron(iii)-complexes and redox substances
12/11/2012US8330026 Derivatives of the NF-κB inducing enzyme, their preparation and use
12/11/2012US8329928 Compounds, compositions and methods
12/11/2012US8329900 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; preparing, for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile
12/11/2012US8329742 Macrocyclic compounds useful as pharmaceuticals
12/11/2012US8329701 Dihydrofuro pyrimidines as AKT protein kinase inhibitors
12/11/2012US8329662 Prodrug of an ICE inhibitor
12/11/2012US8329643 PIMAP39 modulates LPS-induced inflammatory response
12/11/2012US8329637 Immunosuppression and antigen-specific immune tolerance; allogenic organ rejection, graft versus host disease, type I diabetes, rheumatoid arthritis, multiple sclerosis, systemic lupus erithematosus; chronic inflammatory disease; Crohn's disease and ulcerative colitis; asthma
12/11/2012US8329190 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
12/11/2012US8329180 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
12/11/2012CA2576144C Sigma receptor inhibitors
12/11/2012CA2561975C Substituted diaza-spiro-[4.5]-decane derivatives and their use as neurokinin antagonists
12/11/2012CA2549467C A preventive agent for vasculitis
12/11/2012CA2483890C Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
12/11/2012CA2451980C 2-amino-4,5-trisubstituted thiazolyl derivatives and their use against autoimmune disorders
12/11/2012CA2284459C Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
12/06/2012WO2012167133A2 Inhibitors of anandamide transport and their therapeutic uses
12/06/2012WO2012167077A1 Blockade of inflammatory proteases with theta - defensins
12/06/2012WO2012166983A1 Tricyclic inhibitors of poly(adp-ribose)polymerase
12/06/2012WO2012166844A2 Treatment of pain using placental stem cells
12/06/2012WO2012164118A1 Bioactive polyphenolic compounds containing sulphur or selenium and uses thereof
12/06/2012WO2012163934A1 Amino-substituted-alkyloxy-benzo[e]pyrido[4,3-b]indole derivatives as new potent kinase inhibitors
12/06/2012WO2012163933A1 Amino-substituted-alkyloxy-benzo[e]pyrido[4,3-b]indole derivatives as new potent kinase inhibitors
12/06/2012WO2012163724A1 Triazolopyridine compounds
12/06/2012US20120310144 Vision through photodynamic therapy of the eye
12/06/2012US20120309841 Method of Inhibiting Chronification of Pain
12/06/2012US20120309836 Methods and compositions for administration of trpv1 agonists
12/06/2012US20120309833 Novel bexarotene analogs
12/06/2012US20120309826 Stabilized pediatric suspension of carisbamate
12/06/2012US20120309818 Chronic inflammation and transplantation
12/06/2012US20120309808 Compositions and methods for epigenetic modification of nucleic acid sequences
12/06/2012US20120309800 Metalloenzyme inhibitor compounds
12/06/2012US20120309792 Tetrazole derivatives as nicotinic acetylcholine receptor modulators
12/06/2012US20120309784 Triazolopyridine kinase inhibitors useful for the treatment of degenerative and inflammatory diseases
12/06/2012US20120309776 Pyrrolo[2,3-d]pyrimidine urea compounds as jak inhibitors
12/06/2012US20120309769 N-benzylindole modulators of pparg
12/06/2012US20120309768 Novel tubulin polymerisation inhibitors
12/06/2012US20120309765 5-anilinoimidazopyridines and methods of use
12/06/2012US20120309760 Piperazine compound having a pgds inhibitory effect
12/06/2012US20120309758 Modulators of atp-binding cassette transporters
12/06/2012US20120309757 N-biphenylmethylindole modulators of pparg
12/06/2012US20120309755 Novel compounds
12/06/2012US20120309749 Piroxicam-Containing Transdermally Absorbable Preparation
12/06/2012US20120309747 Protein kinase inhibitors
12/06/2012US20120309743 Thiolactams and uses thereof
12/06/2012US20120309738 Novel compounds
12/06/2012US20120309735 Aminopyrimidines as syk inhibitors
12/06/2012US20120309725 Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
12/06/2012US20120309723 Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases
12/06/2012US20120309722 Therapeutic regimens for the treatment of immunoinflammatory disorders
12/06/2012US20120309719 (22e)-2-methylene-26,27-cyclo-22-dehydro-1alpha-hydroxy-19-norvitamin d3 derivatives
12/06/2012US20120309709 Ion-Channel Regulator Compositions and Methods of Using Same
12/06/2012US20120309699 Compounds having anti-inflammatory activity
12/06/2012US20120309686 Treatment of Rheumatoid Arthritis With Mammal Beta Defensins
12/06/2012US20120309677 Methods for regulating blood glucose levels
12/06/2012US20120309674 Pseudodipeptides as mmp inhibitors
12/06/2012US20120309672 Treatment of extracellular matrix to reduce inflammation
12/06/2012US20120309628 Bioactive agent delivery particles
12/06/2012US20120308677 Pharmaceutical Composition for Preventing and Treating Inflammatory Diseases Containing an Ethyl Acetate Fraction of Dried Extract of Trachelospermi Caulis as an Active Ingredient, and Method for Producing the Fraction
12/06/2012US20120308674 Composition and method for the treatment of neuropathic pain
12/06/2012US20120308659 Pellet formulation for the treatment of the intenstinal tract
12/06/2012US20120308647 Use of mir-30e to treat vascular lesions
12/06/2012US20120308645 Compositions and methods for sirna inhibition of hif-1 alpha
12/06/2012US20120308644 Compositions for mucosal delivery of agents
12/06/2012US20120308637 Compositions comprising extracts of boswellia, tea tree, aloe and lavender oil and methods of treating wounds, burns and skin injuries therewith
12/06/2012US20120308610 Materials and Methods for Altering an Immune Response to Exogenous and Endogenous Immunogens, Including Syngeneic and Non-Syngeneic Cells, Tissues or Organs
12/06/2012US20120308606 Bicyclic derivatives as modulators of voltage gated ion channels
12/06/2012US20120308589 Sinomenine derivatives, synthetic methods and uses thereof
12/06/2012US20120308588 Neprilysin inhibitors
12/06/2012US20120308586 Composition based on extra virgin olive oils
12/06/2012US20120308585 Methods and compositions for use in cellular therapies
12/06/2012US20120308581 Compositions and methods for detecting tlr3
12/06/2012US20120308574 Human monoclonal antibody that specifically binds to vcam-1 and a composition for treating an inflammatory disease or a cancer comprising the same
12/06/2012US20120308570 Methods for treating diseases
12/06/2012US20120308568 Pharmaceutical composition for inhibiting abnormal proliferation of cells
12/06/2012US20120308565 Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof
12/06/2012US20120308553 Oral medication for the treatment of hemorrhoids and method of use
12/06/2012US20120308545 Crystallized Oxalate Decarboxylase and Methods of Use
12/06/2012US20120308535 Pharmaceutical Composition Containing Expanded Adult Stem Cells and Methods of Using Same for Treatment
12/06/2012US20120308529 Compositions comprising adipose stem cells
12/06/2012US20120308523 Method for Reducing Gastro-Intestinal Inflammation Using Bifidobacterium Animalis Bacteria or a Fermented Dairy Product Comprising Such Bacteria
12/06/2012US20120308515 Use of gilz protein expressed in dendritic cells to modulate an antigen-specific immune response
12/06/2012US20120308483 Treatment of Sleep Disturbances
12/06/2012US20120308480 Humanized antibodies against tl1a
1 ... 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 ... 1272